Docusign (NASDAQ:DOCU) Receives Hold (C) Rating from Weiss Ratings

Key Points

• Docusign received a "hold (C)" rating from Weiss Ratings, with a consensus rating of "Hold" and an average price target of $94.14 among analysts.
• Recent earnings reports revealed Docusign beat expectations with $0.92 EPS and $800.64 million in revenue for the quarter, indicating an 8.8% year-over-year revenue growth.
• Insider trading activity saw notable sales, with key executives selling shares, demonstrating a decrease in their ownership positions while institutional investors have largely increased their stakes in the company.

Docusign (NASDAQ:DOCU - Get Free Report)'s stock had its "hold (c)" rating reiterated by investment analysts at Weiss Ratings in a research note issued on Friday,Weiss Ratings reports.

Several other research firms have also recently commented on DOCU. Piper Sandler raised their target price on Docusign from $85.00 to $90.00 and gave the company a "neutral" rating in a research report on Friday, September 5th. Citigroup raised their target price on Docusign from $110.00 to $115.00 and gave the company a "buy" rating in a research report on Thursday, September 4th. Wells Fargo & Company lifted their price target on Docusign from $80.00 to $85.00 and gave the company an "equal weight" rating in a research report on Friday, September 5th. Zacks Research upgraded Docusign from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, September 9th. Finally, Royal Bank Of Canada lifted their price target on Docusign from $90.00 to $95.00 and gave the company a "sector perform" rating in a research report on Friday, September 5th. One research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and fifteen have given a Hold rating to the company. Based on data from MarketBeat, Docusign has a consensus rating of "Hold" and an average price target of $94.14.

Docusign Price Performance

DOCU opened at $71.49 on Friday. Docusign has a 12 month low of $66.35 and a 12 month high of $107.86. The stock has a market cap of $14.38 billion, a P/E ratio of 53.75, a P/E/G ratio of 3.53 and a beta of 1.02. The stock's 50 day moving average price is $75.23 and its 200 day moving average price is $77.84.

Docusign (NASDAQ:DOCU - Get Free Report) last posted its earnings results on Thursday, September 4th. The company reported $0.92 EPS for the quarter, beating the consensus estimate of $0.84 by $0.08. Docusign had a return on equity of 14.01% and a net margin of 9.08%.The firm had revenue of $800.64 million for the quarter, compared to analysts' expectations of $780.35 million. During the same period last year, the firm earned $0.97 EPS. The firm's revenue was up 8.8% compared to the same quarter last year. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. Equities analysts anticipate that Docusign will post 1.17 EPS for the current year.

Insider Buying and Selling at Docusign

In other news, insider James P. Shaughnessy sold 7,500 shares of the firm's stock in a transaction on Wednesday, October 1st. The stock was sold at an average price of $71.19, for a total transaction of $533,925.00. Following the completion of the sale, the insider directly owned 55,442 shares of the company's stock, valued at $3,946,915.98. This trade represents a 11.92% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Blake Jeffrey Grayson sold 6,500 shares of the firm's stock in a transaction on Wednesday, October 1st. The stock was sold at an average price of $71.20, for a total value of $462,800.00. Following the sale, the chief financial officer directly owned 105,660 shares of the company's stock, valued at approximately $7,522,992. This represents a 5.80% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 102,533 shares of company stock worth $7,709,933. 1.01% of the stock is owned by insiders.

Institutional Investors Weigh In On Docusign

Large investors have recently modified their holdings of the stock. Oak Family Advisors LLC boosted its stake in shares of Docusign by 37.2% during the 2nd quarter. Oak Family Advisors LLC now owns 95,134 shares of the company's stock worth $7,410,000 after acquiring an additional 25,795 shares in the last quarter. New Age Alpha Advisors LLC boosted its position in shares of Docusign by 738.2% in the first quarter. New Age Alpha Advisors LLC now owns 41,187 shares of the company's stock worth $3,353,000 after buying an additional 36,273 shares during the period. Pinpoint Asset Management Ltd boosted its position in shares of Docusign by 54.3% in the first quarter. Pinpoint Asset Management Ltd now owns 56,985 shares of the company's stock worth $4,639,000 after buying an additional 20,043 shares during the period. Concurrent Investment Advisors LLC acquired a new stake in shares of Docusign in the first quarter worth $618,000. Finally, QRG Capital Management Inc. boosted its position in shares of Docusign by 6.6% in the second quarter. QRG Capital Management Inc. now owns 70,583 shares of the company's stock worth $5,498,000 after buying an additional 4,341 shares during the period. 77.64% of the stock is owned by institutional investors.

About Docusign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.